Noninfectious Granulomas in Pigmented Skin

  • Nour KibbiEmail author
  • Abdul-Ghani Kibbi


Granulomatous skin diseases are a diverse group of disorders as chronic inflammatory responses to infectious and noninfectious antigens and/or other organic or inorganic materials the immune system is unable to eliminate. The diagnosis of granulomatous diseases relies heavily on clinical and pathological examination; the unifying finding is an inflammatory infiltrate predominantly composed of histiocytes, macrophages, and giant cells, sometimes showing collagen degeneration and caseation necrosis. The clinical manifestations are generally rare and may differ in their incidence and presentation in individuals with heavily pigmented ethnic skin.


  1. 1.
    Rybicki BA, Major M, Popovich J, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–41.CrossRefPubMedGoogle Scholar
  2. 2.
    Edmondstone WM, Wilson AG. Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest. 1985;79:27–36.CrossRefPubMedGoogle Scholar
  3. 3.
    Jacyk WK. Cutaneous sarcoidosis in black South Africans. Int J Dermatol. 1999;38:841–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Marchell RM, Judson MA. Chronic cutaneous lesions of sarcoidosis. Clin Dermatol. 2007;25:295–302.CrossRefPubMedGoogle Scholar
  5. 5.
    Minus HR, Grimes PE. Cutaneous manifestations of sarcoidosis in blacks. Cutis. 1983;32:361–3.PubMedGoogle Scholar
  6. 6.
    Sharma SK, Mohan A, Guleria JS. Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis. J Assoc Physicians India. 2001;49:697–704.PubMedGoogle Scholar
  7. 7.
    Roustan G, Yebra M, Rodriguez-Braojos O, et al. Cutaneous and pulmonary sarcoidosis in a patient with HIV after highly active antiretroviral therapy. Int J Dermatol. 2007;46:68–71.CrossRefPubMedGoogle Scholar
  8. 8.
    Ramos-Casals M, Maña J, Nardi N, et al. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore). 2005;84(2):6.Google Scholar
  9. 9.
    Doherty CB, Rosen T. Evidence-based therapy for cutaneous sarcoidosis. Drugs. 2008;68:1361–83.CrossRefPubMedGoogle Scholar
  10. 10.
    Lee JB, Koblenzer PS. Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report. J Am Acad Dermatol. 1998;39:835–8.Google Scholar
  11. 11.
    Georgiou S, Monastirli A, Pasmatzi E, et al. Cutaneous sarcoidosis: complete remission after oral isotretinoin therapy. Acta Derm Venereol. 1998;78:457–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Dhaille F, Viseux V, Caudron A, et al. Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases. Dermatology. 2010;220:234–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Patterson JW, Fitzwater JE. Treatment of hypopigmented sarcoidosis with 8-methoxypsoralen and long wave ultraviolet light. Int J Dermatol. 1982;21:476–80.CrossRefPubMedGoogle Scholar
  14. 14.
    Behbehani N, Jayakrishnan B, Khadadah M, et al. Long-term prognosis of sarcoidosis in Arabs and Asians: predictors of good outcome. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23:209–14.PubMedGoogle Scholar
  15. 15.
    Studer EM, Calza AM, Saurat JH. Precipitating factors and associated diseases in 84 patients with granuloma annulare: a retrospective study. Dermatology. 1996;193:364–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Muhlemann MF, Williams DR. Localized granuloma annulare is associated with insulin-dependent diabetes mellitus. Br J Dermatol. 1984;111:325.CrossRefPubMedGoogle Scholar
  17. 17.
    Wu W, Robinson-Bostom L, Kokkotou E, et al. Dyslipidemia in granuloma annulare: a case-control study. Arch Dematol. 2012;148:1131–6.Google Scholar
  18. 18.
    Li A, Hogan DJ, Sanusi ID, et al. Granuloma annulare and malignant neoplasms. Am J Dermatopathol. 2003;25:113–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Barksdale SK, Perniciaro C, Hailing KC, et al. Granuloma annulare in patients with malignant lymphoma: clinicopathologic study of thirteen new cases. J Am Acad Dermatol. 1994;31:42–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Evans MJ, Blessing K, Gray E. Pseudorheumatoid nodule (deep granuloma annulare) of childhood: clinicopathologic features of twenty patients. Pediatr Dermatol. 1994;11:6–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Chiang K, Bhalla R, Mesinkovska NA, et al. Periocular granuloma annulare: a case report and review of literature. Pediatr Dermatol. 2014;31:722–5.CrossRefPubMedGoogle Scholar
  22. 22.
    Ratnavel RC, Norris PG. Perforating granuloma annulare: response to treatment with isotretinoin. J Am Acad Dermatol. 1995;32:126–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Simon M Jr, von den Driesch P. Antimalarials for control of disseminated granuloma annulare in children. J Am Acad Dermatol. 1994;31:1064–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Spadino S, Altomare A, Cainelli C, et al. Disseminated granuloma annulare: efficacy of cyclosporine therapy. Int J Immunopathol Pharmacol. 2006;19:433–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Peyri J, Moreno A. Marcoval: necrobiosis lipoidica. Semin Cutan Med Surg. 2007;26:87–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Boulton AJM, Cutfield RG, Abouganem D, et al. Necrobiosis lipoidica diabeticorum: a clinicopathologic study. J Am Acad Dermatol. 1988;18:530–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Quimby SR, Muller SA, Schroeter AL. The cutaneous immunopathology of necrobiosis lipoidica diabeticorum. Arch Dermatol. 1988;124:1364–71.CrossRefPubMedGoogle Scholar
  28. 28.
    Uva L, Freitas J, Soares de Almeida L, et al. Squamous cell carcinoma arising in ulcerated necrobiosis lipoidica diabeticorum. Int Wound J. 2015;12:741–3.CrossRefPubMedGoogle Scholar
  29. 29.
    Petzelbauer P, Wolff K, Tappeiner G. Necrobiosis lipoidica: treatment with systemic corticosteroids. Br J Dermatol. 1992;126:542–5.CrossRefPubMedGoogle Scholar
  30. 30.
    Beattie PE, Dawe RS, Ibbotson SH, et al. UVA1 phototherapy for treatment of necrobiosis lipoidica. Clin Exp Dermatol. 2006;31:235–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Dogliotti M, Leibowitz M. Granulomatous ochronosis—a cosmetic-induced skin disorder in blacks. S Afr Med J. 1979;56:757–60.PubMedGoogle Scholar
  32. 32.
    Baumgartner M, Feldmann R, Breier F, et al. Sarcoidal granulomas in a cosmetic tattoo in association with pulmonary sarcoidosis. J Dtsch Dermatol Ges. 2010;8:900–2.PubMedGoogle Scholar
  33. 33.
    Collins P, Evans AT, Gray W, et al. Pulmonary sarcoidosis presenting as a granulomatous tattoo reaction. Br J Dermatol. 1994;130:658–62.CrossRefPubMedGoogle Scholar
  34. 34.
    Suvanasuthi S, Wongpraparut C, Pattanaprichakul P, et al. Mycobacterium fortuitum cutaneous infection from amateur tattoo. J Med Assoc Thail. 2012;95:834–7.Google Scholar
  35. 35.
    Sherif S, Blakeway E, Fenn C, et al. A case of squamous cell carcinoma developing within a red-ink tattoo. J Cutan Med Surg. 2017;21:61–3. pii: 1203475416661311.CrossRefPubMedGoogle Scholar
  36. 36.
    da Mota LM, Laurindo IM, dos Santos Neto LL. Demographic and clinical characteristics of a cohort of patients with early rheumatoid arthritis. Rev Bras Rheumatol. 2010;50:235–48.CrossRefGoogle Scholar
  37. 37.
    Mebazaa A, Aounallah A, Naija N, et al. Dermatologic manifestations in inflammatory bowel disease in Tunisia. Tunis Med. 2012;90:252–7.PubMedGoogle Scholar
  38. 38.
    Wollina U, Haroske G. Pyoderma gangraenosum. Curr Opin Rheumatol. 2011;23:50–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of DermatologyYale UniversityNew HavenUSA
  2. 2.Department of DermatologyAmerican University of Beirut Medical CenterBeirutLebanon

Personalised recommendations